Based on this assay, we found that HO-1 is highly expressed after treatment with TChal in a dose- and time-dependent manner in BT-20 cells, as well in the MDA-MB-231 and TPC-1 cell lines, indicating that this phenomenon happens in other cancer cells. This evidence concerns the gene HMOX1 and cancer.